| Parameter |
RefValues (children) |
P1 | P2 |
| Lymphocyte (n°/μL) | 2500-6000 | 809 | 879 |
| T Cells | |||
| CD3+ n°/μL (%) | 1400-4300(52-88) | 60 (7) | 661 (75) |
| TCRαβ (%) | 85-99 | 5 | 54 |
| TCRγδ (%) | 2-15 | 1 | 16 |
| CD3+HLA-DR+ (%) | 0-10 | 22 | 7 |
| DNT (%) | 0-2.5 | 0.2 | 0.7 |
| CD4+ n°/μL (%) | 1000-2500(33-55) | 53 (7) | 304 (35) |
| CD4+CD45RA+CCR7+(Naïve) (%) | 32-82 | 4.1 | 45.4 |
| CD4+CD45RA+CCR7- (CM) (%) | 15-30 | 41.5 | 28.9 |
| CD4+CD45RA-CCR7- (EM) (%) | 8-30 | 53.9 | 23.8 |
| CD4+CD45RA-CCR7+ (E) (%) | 0.4-4 | 0.4 | 1.89 |
| CD4+CD45RA+CD31+ (%) | 44-60 | 2 | |
| CD8+ n°/μL (%) | 400-1400(17-34) | 6 (1) | 264 (30) |
| CD8+CD45RA+CCR7+(Naïve) (%) | 30-80 | 15.3 | 72.0 |
| CD8+CD45RA+CCR7- (CM) (%) | 3-28 | 16.2 | 4.5 |
| CD8+CD45RA-CCR7- (EM) (%) | 17-40 | 59.5 | 16.7 |
| CD4+CD45RA-CCR7+ (TEMRA) (%) | 2-15 | 9 | 6.8 |
| TRECS (copies/punch) | > 10 | < 10 | 50 |
| NK Cells | |||
| CD56+CD3- n°/μL (%) | 100-650(2-20) | 671 (83) | 191 (21.7) |
| B Cells | |||
| CD19+ n°/μL (%) | 400-1500(9-28) | 49 (6) | 22 (2.5) |
| CD19+CD27+ (%) | 7-19 | 32 | |
| CD19+IgD-CD27+ (%Naïve) | 75-89 | 63 | |
| CD19+IgD+CD27+ (%MZ) | 2.6-7.1 | 14.9 | |
| CD19+IgD-CD27+ (%SW) | 4.5-20 | 17.10 | |
| CD19+CD38hiIgM+ (%Transitional) | 3-10 | 13 | |
| Plasmablasts | 0.5-5 | 4.6 | |
| KRECS (copies/punch) | >10 | <10 | 100 |
| Serum Immunoglobulins (mg/dl) | |||
| IgG (mg/dL) | 600-1230 | 446 | 779 |
| IgA (mg/dL) | 30-200 | 18 | <6.67 |
| IgM (mg/dL) | 50-200 | 40 | 109 |
| Specific antibodies | |||
| IgG vs Pneumococcus (mg/dL) | >5.4 | 2.9 | |
| IgG2 vs Pneumococcus (mg/dL) | >2.4 | 0.36 | |
| IgG vs Tetanus toxoid (IU/mL) | >0.1 | 9.10 |